Status | Study |
Recruiting |
Study Name: Treatment of Macrophage Activation Syndrome (MAS) With Anakinra Condition: Macrophage Activation Syndrome Date: 2016-05-11 Interventions: Drug: kineret anakinra adminis |
Recruiting |
Study Name: Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome(MAS) Condition: Macrophage Activation Syndrome Date: 2015-10-02 Interventions: Drug: Interleukin-2 Recombinant Human Interleukin-2 (RhIL-2) was administered subcutaneously at a dose o |
Recruiting |
Study Name: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant Condition: Chronic Myeloid Leukemia (CML) Acute Myelogenous Leukemia (AML); Date: 2014-02-11 Interventions: Device: CliniMACS CD34+ Reagent System |
Recruiting |
Study Name: CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease Condition: Bone Marrow Failure Syndrome Severe Aplastic Anemia Severe Date: 2013-10-17 Interventions: Biological: CD34 Stem Cell Selection Therapy The CliniMacs (PLUS) Reagent System (Miltenyi CliniMacs CD3 |
Recruiting |
Study Name: New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome Condition: Macrophage Activation Syndrome Lymphohistiocytosis, Hemophagocy Date: 2010-03-29 |